Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-05-07 @ 4:42 PM
Study NCT ID:
NCT04828005
Status:
COMPLETED
Last Update Posted:
2025-07-14
First Post:
2021-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacodynamic Evaluation of Intranasal Nalmefene
Sponsor:
Opiant Pharmaceuticals Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OPNT003-PD-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None